Page last updated: 2024-08-26

12-deoxyphorbolphenylacetate and HIV Coinfection

12-deoxyphorbolphenylacetate has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blumberg, PM; Bocklandt, S; Hamer, DH1

Other Studies

1 other study(ies) available for 12-deoxyphorbolphenylacetate and HIV Coinfection

ArticleYear
Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate.
    Antiviral research, 2003, Volume: 59, Issue:2

    Topics: Anti-HIV Agents; Carcinogens; CD4 Antigens; Cell Line; Down-Regulation; Gene Expression Profiling; HIV Infections; HIV-1; Humans; Macromolecular Substances; Models, Molecular; Oligonucleotide Array Sequence Analysis; Phorbol Esters; Protein Kinase C; Receptors, CXCR4; Virus Activation; Virus Replication

2003
chemdatabank.com